AUG. 22, 2017 Munich Re & In-Q-Tel Select Metabiota to Gain Deeper Insights into Epidemic Risk and Global Preparedness for Infectious Diseases https://www.iqt.org/news/munich-re-in-q-tel-select-metabiota-to-gain-deeper-insights-into-epidemic-risk-and-global-preparedness-for-infectious-diseases/
May 2018: Global broker and risk consultancy Marsh has launched PathogenRX, an insurance product designed to protect businesses against pandemic risks such as the outbreak of infectious diseases, that utilises a parametric trigger provided by epidemic risk modeling specialists Metabiota and capacity from reinsurance giant Munich Re.
The impact of infectious disease outbreaks and other pandemics can be significant for businesses, ranging from direct impacts to extensive business interruption, which makes a parametric triggered event definition and risk transfer solution, backed by global reinsurance capacity a valuable product for corporate risk managers.
Of course this also meets the mandate of the major reinsurers such as Munich Re, bringing their reinsurance risk capital direct to the corporate market through such arrangements, while also helping to narrow an evident gap in traditional re/insurance protection. https://www.artemis.bm/news/marsh-munich-re-metabiota-launch-parametric-pandemic-insurance/
Metabiota, the US company funded by US Department of Defence’s Threat Reduction Agency (“DTRA”) to operate biolabs in Ukraine, was founded by Nathan Wolfe who is linked to the Global Virome Project, EcoHealth, World Economic Forum and Jeffrey Epstein.
Wolfe, directly and/or through Metabiota and its sister non-profit Global Viral, is not only been funded by various branches of US Department of Defence but, is also funded by Hunter Biden’s Rosemont Seneca and CIA venture capital company In-Q-Tel. And this is merely scratching the surface of those backing the biolabs in Ukraine.
https://vaccineimpact.com/2022/biolabs-in-ukraine-who-are-metabiotas-investors/
Now Dave Emory.
https://spitfirelist.com/for-the-record/ftrs-1251-and-1252-pandemics-inc-parts-1-and-2/?utm_source=feedburner&utm_medium=email